Impact Of DRGs On Clinical Research Less Than First Feared, Speakers Tell NIH Directors Meeting
In Brief: Calabresi Named DCT Board Chairman; NCI Gets $5 Million Gifts for Intramural Breast Cancer Work
Organ Systems Program Finally Loses a Couple, But Gets OK for Breast Cancer Risk Study RFA
Other Concepts Approves By DCE Board Last Week
New Cancer Education Program “Striking Change,” To Fund CR, Prebaccalaureate, Summer Training
Adamson Rips “Rip Van Bailer”
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









